| Log in

Carlyle, Signet & OrbiMed part exit Claris Lifesciences

11 June, 2014

Private equity investors Carlyle, Signet Healthcare and OrbiMed Advisors have partially exited their investment in pharmaceutical firm Claris Lifesciences participating in the comp ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Carlyle-backed Claris Lifesciences comes up with buyback offer, promoters to participate

Carlyle-backed Claris Lifesciences comes up with buyback offer, promoters to participate

Lohit Jagwani 4 years ago
Ahmedabad-based pharmaceutical company Claris Lifesciences Ltd has received a go...
Carlyle exits Claris Lifesciences with around 2x in nine years

Carlyle exits Claris Lifesciences with around 2x in nine years

TEAM VCC 3 years ago
Private equity investor Carlyle has exited its nine-year-old investment in...
Healthcare-focused investor OrbiMed buys stake in Claris Lifesciences

Healthcare-focused investor OrbiMed buys stake in Claris Lifesciences

Madhav A Chanchani 5 years ago
A fund managed by the private equity firm OrbiMed Advisors has picked up close...
No Comments

Carlyle, Signet & OrbiMed part exit Claris Lifesciences

Powered by WordPress.com VIP